• Explore /
  • Poster
  • / Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in pts with metastatic castration-resistant prostate cancer (mCRPC) receiving a new agent (NA)- based third-line treatment: Final results from a multicenter Italian study.

Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in pts with metastatic castration-resistant prostate cancer (mCRPC) receiving a new agent (NA)- based third-line treatment: Final results from a multicenter Italian study.

Abstract Poster

Authors

null

Orazio Caffo

Medical Oncology, Santa Chiara Hospital, Trento, Italy

Orazio Caffo , Emilio Bria , Ugo De Giorgi , Marcello Tucci , Luca Galli , Lucia Fratino , Sabrina Rossetti , Roberto Iacovelli , Giovanni Lo Re , Claudia Mosillo , Donatello Gasparro , Pamela Guglielmini , Azzurra Damiani , Giuseppe Procopio , Delia De Lisi , Cinzia Ortega , Sarah Scagliarini , Maddalena Donini , Isabella Sperduti , Umberto Basso

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 230)

DOI

10.1200/JCO.2017.35.6_suppl.230

Abstract #

230

Poster Bd #

J8

Abstract Disclosures

Similar Posters

First Author: Orazio Caffo

First Author: Celestia S. Higano

First Author: Orazio Caffo

First Author: Orazio Caffo